Related Experiment Videos
p53-dependent DNA damage-induced apoptosis requires Fas/APO-1-independent activation of CPP32beta
E J Fuchs1, K A McKenna, A Bedi
1Johns Hopkins Oncology Center, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA.
Abstract:
In many cell types, the p53 tumor suppressor protein is required for the induction of apoptosis by DNA-damaging chemotherapy or radiation. Therefore, identification of the molecular determinants of p53-dependent cell death may aid in the design of effective therapies of p53-deficient cancers. We investigated whether p53-dependent apoptosis requires activation of CPP32beta (caspase 3), a cysteine protease that has been found to mediate apoptosis in response to ligation of the Fas molecule or to granzyme B, a component of CTL lytic granules. Irradiation-induced apoptosis was associated with p53-dependent activation of CPP32beta-related proteolysis, and normal thymocytes were protected from irradiation by Acetyl-Asp-Glu-Val-Asp-CHO (Ac-DEVD-CHO), a specific inhibitor of CPP32beta. We next examined whether the Fas system is required for p53-dependent apoptosis and whether stimuli that induce activation of CPP32beta induce apoptosis in p53-deficient cells. Thymocytes or activated T cells from Fas-deficient mice were resistant to apoptosis induced by ligation of Fas or CD3, respectively, but remained normally susceptible to irradiation. Thymocytes from p53-deficient mice, although resistant to DNA damage, remained sensitive to CPP32beta-mediated apoptosis induced by ligation of Fas or CD3, or by exposure to cytotoxic T cells. These results demonstrate that DNA damage-induced apoptosis of T cells requires p53-mediated activation of CPP32beta by a mechanism independent of Fas/FasL interactions and suggest that immunological or molecular methods of activating CPP32beta may be effective at inducing apoptosis in p53-deficient cancers that are resistant to conventional chemotherapy or irradiation.
Insights
p53 protein is crucial for DNA damage-induced apoptosis via CPP32beta (caspase 3) activation. Activating CPP32beta may treat p53-deficient cancers resistant to conventional therapies.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Biology
Background:
- p53 tumor suppressor protein is essential for apoptosis induction by DNA damage.
- Understanding p53-dependent cell death mechanisms is key for treating p53-deficient cancers.
Purpose of the Study:
- To investigate if p53-dependent apoptosis requires CPP32beta (caspase 3) activation.
- To explore the role of the Fas system in p53-dependent apoptosis.
- To assess CPP32beta activation in p53-deficient cells.
Main Methods:
- Irradiation of thymocytes and T cells.
- Inhibition of CPP32beta using Ac-DEVD-CHO.
- Fas ligation and CD3 stimulation.
- Analysis of apoptosis in wild-type, p53-deficient, and Fas-deficient mice.
Main Results:
- Irradiation-induced apoptosis showed p53-dependent CPP32beta activation.
- CPP32beta inhibition protected normal thymocytes from irradiation-induced apoptosis.
- p53-deficient thymocytes were sensitive to CPP32beta-mediated apoptosis induced by Fas or CD3 ligation.
- DNA damage-induced apoptosis in T cells is p53-mediated and Fas-independent.
Conclusions:
- p53-mediated activation of CPP32beta is essential for DNA damage-induced apoptosis in T cells.
- This pathway is independent of Fas/FasL interactions.
- Targeting CPP32beta may offer a therapeutic strategy for p53-deficient cancers resistant to standard treatments.